What are the side effects of prazosin and other medications used to treat nightmares, such as clonidine, olanzapine, risperidone, aripiprazole, nabilone, gabapentin, cyproheptadine, fluvoxamine, topiramate, trazodone, triazolam, and nitrazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Side Effects of Medications for Nightmares

Prazosin is generally well-tolerated with the most common side effects being orthostatic hypotension, dizziness, and transient lightheadedness, while most other medications used for nightmares carry more significant adverse effect profiles including sedation, metabolic effects, and extrapyramidal symptoms.

Prazosin Side Effects

Based on the American Academy of Sleep Medicine guideline 1, prazosin demonstrates a favorable safety profile across multiple trials:

Common side effects:

  • Orthostatic hypotension and dizziness - the most frequently reported adverse events 2
  • Transient dizziness (reported in 18% of pediatric patients) 3
  • First-dose hypotension requiring careful titration 4
  • Risk of syncope, particularly in elderly patients

Important tolerability findings:

  • In multiple RCTs, "no significant blood pressure changes or other side effects were noted" at lower doses 1
  • Only two subjects in one study experienced mild orthostatic systolic blood pressure reductions that resolved during treatment 1
  • "Prazosin was generally well-tolerated except for several subjects who experienced transient dizziness; there were no falls or syncopal episodes" 1

Rare paradoxical effects:

  • One case report documented prazosin actually causing nightmares and sleep disturbances in an elderly patient, though this is extremely uncommon 5
  • Headaches (6% in pediatric population) 3
  • Anxiety (9% in pediatric population) 3

Clinical pearls for prazosin:

  • Start low and titrate slowly to minimize orthostatic effects
  • Monitor blood pressure, especially after first dose and dose increases
  • Particular caution in elderly patients who may be more susceptible to hypotensive effects
  • The medication is generally well-tolerated with adverse events consistent with its alpha-1 blocking mechanism 3

Atypical Antipsychotics Side Effects

Olanzapine

Based on comparative data 6:

  • Sedation is the primary side effect (28.6% of patients)
  • Metabolic effects including weight gain, hyperglycemia, and dyslipidemia (from general medical knowledge)
  • Lower risk of extrapyramidal symptoms compared to typical antipsychotics

Risperidone

From the comparative study 6:

  • Extrapyramidal symptoms (4.8% of cases) - lower than haloperidol but still present
  • Hyperprolactinemia with associated sexual dysfunction and galactorrhea
  • Weight gain and metabolic effects
  • Sedation (though less than olanzapine)

Aripiprazole

The FDA label 7 provides comprehensive safety data:

Common adverse reactions (≥5% in overdose cases):

  • Vomiting
  • Somnolence
  • Tremor

Serious adverse reactions from overdose/toxicity:

  • Cardiovascular: atrial fibrillation, bradycardia, hypertension, hypotension, QT prolongation, tachycardia
  • Neurological: convulsion, status epilepticus, lethargy, loss of consciousness, coma
  • Metabolic: hypokalemia, elevated creatine phosphokinase
  • Respiratory: aspiration pneumonia, respiratory arrest

Clinical considerations:

  • Highly protein-bound (hemodialysis ineffective in overdose)
  • Generally better metabolic profile than olanzapine or risperidone
  • Lower sedation compared to other atypicals

Benzodiazepines Side Effects

Triazolam

The FDA label 8 provides detailed safety information:

Most common side effects (>5%):

  • Drowsiness (14% of patients) - the most frequent adverse effect
  • Headache (9.7%)
  • Dizziness (7.8%)
  • Nervousness (5.2%)
  • Lightheadedness (4.9%)
  • Coordination disorders/ataxia (4.6%)
  • Nausea/vomiting (4.6%)

Serious behavioral effects:

  • Complex sleep behaviors (sleep-walking, sleep-driving, engaging in activities while not fully awake)
  • Anterograde amnesia, including "traveler's amnesia"
  • Paradoxical reactions: agitation, aggression, hallucinations, mania, restlessness
  • Worsening of depression and suicidal thoughts
  • Abnormal thinking and behavior changes

Withdrawal symptoms (1-2 days after discontinuation):

  • Rebound insomnia
  • Unpleasant feelings
  • Stomach and muscle cramps
  • Vomiting, sweating, shakiness
  • Seizures (in severe cases)

Critical warnings:

  • Elderly patients are "especially susceptible to dose-related adverse effects"
  • Risk of dependence and abuse (Schedule IV controlled substance)
  • Contraindicated with potent CYP3A inhibitors (ketoconazole, itraconazole, nefazodone)

Nitrazepam

While not specifically detailed in the provided evidence, this benzodiazepine shares the class effects of triazolam including sedation, cognitive impairment, dependence risk, and withdrawal symptoms.

Other Medications

Clonidine

Not specifically detailed in the provided evidence, but from general medical knowledge:

  • Hypotension and bradycardia
  • Sedation and fatigue
  • Dry mouth
  • Rebound hypertension with abrupt discontinuation

Nabilone (Synthetic Cannabinoid)

The meta-analysis 9 showed nabilone had the highest effect size (g = 1.86) for nightmare reduction, but specific side effect data was not provided in the evidence. From general knowledge:

  • Dizziness and drowsiness
  • Dry mouth
  • Euphoria or dysphoria
  • Cognitive impairment

Gabapentin

Not detailed in provided evidence. From general knowledge:

  • Sedation and dizziness
  • Peripheral edema
  • Weight gain
  • Ataxia

Cyproheptadine

Mentioned in the guideline 1 but specific side effect data not provided. From general knowledge:

  • Sedation (antihistamine effect)
  • Dry mouth
  • Weight gain and increased appetite
  • Dizziness

Topiramate

The guideline 1 mentions topiramate but provides limited side effect data. From general knowledge:

  • Cognitive slowing ("dopamax")
  • Paresthesias
  • Weight loss
  • Metabolic acidosis
  • Kidney stones
  • Acute angle-closure glaucoma (rare but serious)

Fluvoxamine & Trazodone

Not specifically detailed in provided evidence for nightmare treatment context.

Clinical Decision-Making Algorithm

For selecting medication based on side effect profile:

  1. First-line: Prazosin - best evidence base, most favorable side effect profile limited primarily to orthostatic hypotension 1, 4

  2. If prazosin contraindicated or ineffective:

    • Consider alternative alpha-1 blockers (doxazosin, terazosin) 10
    • Monitor blood pressure carefully
  3. If alpha-blockers fail or contraindicated:

    • Nabilone if available - highest effect size but limited data 9
    • Atypical antipsychotics - choose based on side effect tolerance:
      • Aripiprazole: lowest metabolic/sedation risk
      • Risperidone: moderate EPS risk
      • Olanzapine: highest sedation risk (28.6%) 6
  4. Avoid benzodiazepines as first-line due to dependence risk, complex sleep behaviors, and paradoxical reactions 8

Key monitoring parameters:

  • Blood pressure (standing and supine) for alpha-blockers
  • Weight and metabolic parameters for antipsychotics
  • Cognitive function and falls risk in elderly
  • Signs of dependence with benzodiazepines
  • Emergence of paradoxical worsening of nightmares or new psychiatric symptoms

References

Guideline

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Research

Prazosin for treatment of nightmares related to posttraumatic stress disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Research

Clinical update on the use of prazosin for night-time symptoms of PTSD.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2026

Research

Sleep Disturbances and Nightmares in a Patient Treated with Prazosin.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2016

Related Questions

What are the contraindications to initiating prazosin for insomnia?
Can prazosin cause hypnagogic hallucinations?
In an embalming student with nightly nightmares related to embalming for the past eight months, would prazosin be an appropriate treatment?
Can I prescribe prazosin (alpha‑1 blocker) to a 13‑year‑old with vivid nightmares?
What is the recommended starting dose of prazosin for nightmares?
In a 55-year-old man with alcohol‑induced liver cirrhosis and laboratory findings of markedly elevated gamma‑glutamyl transferase (GGT), modestly elevated alkaline phosphatase (ALP), and mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), what further testing is recommended?
What is the best medication regimen for a patient with metabolic dysfunction-associated steatotic liver disease (MASLD) who has hypercholesterolemia and hypertriglyceridemia?
Is there a contraindication to co‑administering furosemide (Lasix) and enoxaparin (Lovenox)?
What are the appropriate ICD‑10‑CM diagnosis code and ICD‑10‑PCS procedure code for excising skin cancer on the nose?
In a 34-year-old male on doxycycline for a presumed bug bite infection for six days who now has a persistent firm, warm area that has not improved, what is the appropriate next step in management?
In a 76‑year‑old man who became hypotensive after taking all four antihypertensive agents, with a recent increase of metoprolol (metoprolol tartrate) from 12.5 mg to 25 mg daily and early‑morning hypoglycemia (glucose 40‑50 mg/dL), how should his blood‑pressure medications be reduced while also managing the hypoglycemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.